Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Toyohara, A. Waki, S. Takamatsu, Y. Yonekura, Y. Magata, Y. Fujibayashi (2002)
Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines.Nuclear medicine and biology, 29 3
Seol Park, J. Ryu, S. Oh, Seung-Il Park, Y. Kim, Hoon-Yong Jung, G. Lee, Ho Song, Jong Kim, Ho-Young Song, K. Cho, Sung-Bae Kim (2012)
The Feasibility of 18F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal CancerNuclear Medicine and Molecular Imaging, 46
K. Sjoquist, Fracp, R. Simes, Gebski Mstat, Alexandra Hospital, A. Brisbane, Peter Brisbane, Cancer Maccallum, Centre, V. Gebski, K. Sjoquist, B. Burmeister, M. Smithers, J. Zalcberg, J. Simes, A. Barbour (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.The Lancet. Oncology, 12 7
T. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, T. Hennessy (1996)
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.The New England journal of medicine, 335 7
E. Ancona, A. Ruol, S. Santi, S. Merigliano, V. Sileni, H. Koussis, G. Zaninotto, L. Bonavina, A. Peracchia (2001)
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinomaCancer, 91
A. Mandard, F. Dalibard, J. Mandard, J. Marnay, M. Henry-Amar, J. Petiot, A. Roussel, J. Jacob, P. Ségol, G. Samama, J. Ollivier, S. Bonvalot, M. Gignoux (1994)
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 73
A. Davies, J. Gossage, J. Zylstra, F. Mattsson, J. Lagergren, N. Maisey, E. Smyth, D. Cunningham, W. Allum, R. Mason (2014)
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 27
S. Apisarnthanarax, M. Alauddin, F. Mourtada, H. Ariga, U. Raju, O. Mawlawi, Dongmei Han, W. Bornmann, J. Ajani, L. Milas, J. Gelovani, K.S.Clifford Chao (2006)
Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3′-Deoxy-3′-3H-Fluorothymidine Using Preclinical Tumor ModelsClinical Cancer Research, 12
Raya Brown, J. Leung, P. Kison, K. Zasadny, A. Flint, R. Wahl (1999)
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 40 4
K. Goodman, D. Niedzwiecki, N. Hall, T. Bekaii-Saab, X. Ye, M. Meyers, Kisha Mitchell-Richards, D. Boffa, W. Frankel, A. Venook, H. Hochster, C. Crane, E. O’Reilly, D. Ilson (2017)
Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.Journal of Clinical Oncology, 35
David Jones, L. Parker, F. Detterbeck, T. Egan (1999)
Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapyCancer, 85
Thomas Schmidt, L. Sicic, S. Blank, K. Becker, Wilko Weichert, Thomas Bruckner, T. Parakonthun, Rupert Langer, M. Büchler, J. Siewert, Florian Lordick, Katja Ott (2014)
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomasBritish Journal of Cancer, 110
R. Siegel, K. Miller, A. Jemal (2017)
Cancer statistics, 2017CA: A Cancer Journal for Clinicians, 67
Haojun Chen, Yimin Li, Hua Wu, Long Sun, Q. Lin, Long Zhao, Hanxiang An (2015)
3’-Deoxy-3’-[18F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancerStrahlentherapie und Onkologie, 191
P. Flamen, E. Cutsem, A. Lerut, J. Cambier, K. Haustermans, G. Bormans, P. Leyn, D. Raemdonck, W. Wever, N. Ectors, A. Maes, L. Mortelmans (2002)
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 13 3
E Ancona, A Ruol, S Santi, S Merigliano, VC Sileni, H Koussis, G Zaninotto (2001)
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery aloneCancer, 91
H. Dittmann, B. Dohmen, R. Kehlbach, Gabi Bartusek, Maren Pritzkow, M. Sarbia, R. Bares (2002)
Early changes in [18F]FLT uptake after chemotherapy: an experimental studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 29
J. Siewert, H. Stein (1998)
Classification of adenocarcinoma of the oesophagogastric junctionBritish Journal of Surgery, 85
E. Prisé, P. Etienne, B. Meunier, G. Maddern, M. Hassel, D. Gédouin, Dominique Boutin, J. Campion, B. Launois (1994)
A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagusCancer, 73
Betty Pio, Cecilia Park, R. Pietras, W. Hsueh, N. Satyamurthy, M. Pegram, J. Czernin, M. Phelps, D. Silverman (2005)
Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to TherapyMolecular Imaging and Biology, 8
B. Brücher, W. Weber, M. Bauer, U. Fink, N. Avril, H. Stein, Martin Werner, F. Zimmerman, J. Siewert, M. Schwaiger (2001)
Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission TomographyAnnals of Surgery, 233
KM Sjoquist, BH Burmeister, BM Smithers, JR Zalcberg, RJ Simes, A Barbour, V Gebski (2011)
Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisLancet Oncol, 12
M. Mamede, G. Fakhri, P. Abreu-e-Lima, W. Gandler, V. Nosé, V. Gerbaudo (2007)
Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmationAnnals of Nuclear Medicine, 21
M. Mamede, P. Abreu-e-Lima, M. Oliva, V. Nosé, H. Mamon, V. Gerbaudo (2007)
FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer: Correlation With Histopathology ResultsAmerican Journal of Clinical Oncology, 30
G. Zuccaro, T. Rice, J. Goldblum, S. Medendorp, M. Becker, R. Pimentel, L. Gitlin, D. Adelstein (1999)
Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancerAmerican Journal of Gastroenterology, 94
V. Oppedijk, A. Gaast, J. Lanschot, P. Hagen, R. Os, C. rij, M. Sangen, J. Beukema, H. Rütten, P. Spruit, J. Reinders, D. Richel, M. Henegouwen, M. Hulshof (2014)
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 5
U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz, P. Kienle, M. Kieser, T. Slanger, B. Burmeister, D. Kelsen, D. Niedzwiecki, C. Schuhmacher, S. Urba, C. Velde, T. Walsh, M. Ychou, K. Jensen (2013)
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.European journal of cancer, 49 15
Meg Perumal, R. Pillai, H. Barthel, Julius Leyton, J. Latigo, M. Forster, F. Mitchell, A. Jackman, E. Aboagye (2006)
Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography.Cancer research, 66 17
J. Yue, Lusheng Chen, A. Cabrera, Xin-dong Sun, Shu-qiang Zhao, F. Zheng, A. Han, Jinsong Zheng, X. Teng, Li Ma, Yi-dong Ma, Dali Han, Xianguang Zhao, D. Mu, Jinming Yu, Yuhui Li (2010)
Measuring Tumor Cell Proliferation with 18F-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical StudyJournal of Nuclear Medicine, 51
H. Wieder, B. Brücher, F. Zimmermann, K. Becker, F. Lordick, A. Beer, M. Schwaiger, U. Fink, J. Siewert, H. Stein, W. Weber (2004)
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 5
S. Urba, M. Orringer, A. Turrisi, M. Iannettoni, A. Forastiere, M. Strawderman (2001)
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 2
W. Blot, S. Devesa, R. Kneller, J. Fraumeni (1991)
Rising incidence of adenocarcinoma of the esophagus and gastric cardia.JAMA, 265 10
K. Herrmann, H. Wieder, A. Buck, M. Schöffel, B. Krause, F. Fend, T. Schuster, C. Büschenfelde, H. Wester, J. Duyster, C. Peschel, M. Schwaiger, T. Dechow (2007)
Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's LymphomaClinical Cancer Research, 13
H Chen, Y Li, H Wu, L Sun, Q Lin, L Zhao (2015)
3′-deoxy-3′-[18F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [18F]-FDG PET/CTStrahlenther Onkol, 191
F. Lordick, K. Ott, B. Krause, W. Weber, K. Becker, H. Stein, S. Lorenzen, T. Schuster, H. Wieder, K. Herrmann, R. Bredenkamp, H. Höfler, U. Fink, C. Peschel, M. Schwaiger, J. Siewert (2007)
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.The Lancet. Oncology, 8 9
S. Swisher, J. Erasmus, M. Maish, A. Correa, H. Macapinlac, J. Ajani, J. Cox, R. Komaki, D. Hong, Hoon Lee, J. Putnam, D. Rice, W. Smythe, Linh Thai, A. Vaporciyan, G. Walsh, Tsung-Teh Wu, J. Roth (2004)
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaCancer, 101
Objective The aim of this prospective pilot study was to investigate the potential of serial FLT-PET/CT compared to FDG- PET/CT to provide an early indication of esophageal cancer response to concurrent neoadjuvant chemoradiation therapy. Methods Five patients with biopsy-proven esophageal adenocarcinomas underwent neoadjuvant chemoradiation (Tx) prior to minimally invasive esophagectomy. The presence of residual tumor was classified histologically using the Mandard et al. criteria, categorizing patients as pathologic responders and non-responders. Participants underwent PET/CT imaging 1 h after intravenous administration of FDG and of FLT on two separate days within 48 h of each other. Each patient underwent a total of 3 scan “pairs”: (1) pre-treatment, (2) during treatment, and (3) post-treatment. Image-based response to therapy was measured in terms of changes in SUVmax (ΔSUV) between pre- and post-therapeutic FLT- and FDG-PET scans. The PET imaging findings were correlated with the pathology results after surgery. Results All tumors were FDG and FLT avid at baseline. Lesion FLT uptake was lower than with FDG. Neoadjuvant chemo- radiation resulted in a reduction of tumor uptake of both radiotracers in pathological responders (n = 3) and non-responders (n = 2). While the difference in the reduction in mean tumor FLT uptake during Tx between responders
Annals of Nuclear Medicine – Springer Journals
Published: Jan 13, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.